Respiratory Virus Testing 2026-2027

Updated September 2026

Respiratory Virus Testing

Cleveland Clinic Laboratories offers several respiratory testing services to healthcare organizations & providers.

SARS-CoV-2 (COVID-19), influenza A/B, and respiratory syncytial virus (RSV) testing is available for the qualitative detection of these viruses in respiratory specimens from individuals with appropriate signs, symptoms, and risk factors.

All three viruses will continue to be in circulation during the 2026-2027 respiratory virus season.

Respiratory Virus Testing Overview

Test Name

COVID, Influenza A/B, & RSV NAAT, Routine (CVFLRS)

Turnaround Time

24 hours from the time of receipt by the laboratory*
Testing is performed 24 hours a day, 7 days a week

Specimen Requirements – Upper Respiratory

Type:
(1) Nasopharyngeal (NP) Swab – preferred 

Volume:
3 mL

Specimen Container:
Universal Transport Media (UTM)

Accepted Alternatives

Type:
• (1) Nasopharyngeal (NP) swab
• (1) Nasal (anterior nares) swab

Volume:
Swab

Transport Media:
• Universal Transport Media (UTM)
• eSwab
• Saline (sterile)
• Viral Transport Media (VTM), including M4RT, M5, or M6

Specimen Requirements – Lower Respiratory

Type:
• Aspirate, tracheal
• Bronchoalveolar Lavage (BAL)
• Sputum

Volume:
1 mL

Transport Container:
Sterile container

Transport Temperature

Refrigerated; transport to the laboratories on cold packs or wet ice.

Stability

Ambient:
Unacceptable

Refrigerated (2-8ºC):
96 hours

Frozen:
Up to 30 days

Rejection Criteria

Swabs used for Group A Strep testing are not acceptable.

Expanded Respiratory Pathogen Panel Test Overview

This test is for immunocompromised patients, severely ill adults who will be hospitalized and have evidence of a lower respiratory tract infection the etiology of which has not been determined, and children who are going to be admitted that are being evaluated for a suspected respiratory viral infection.

This panel should rarely be ordered in the outpatient setting, and if ordered, preauthorization should be strongly considered. The test is very expensive and if not covered by insurance the patient will incur a substantial charge.

Test Name

Expanded Respiratory Pathogen Panel by PCR (with COVID), Routine (RPPCR)

Turnaround Time

2 – 3 days

Specimen Requirements – Upper Respiratory

Type:
(1) Nasopharyngeal (NP) Swab – preferred 

Volume:
3 mL

Specimen Container:
Universal Transport Media (UTM)

Accepted Alternatives

Type:
• (1) Nasopharyngeal (NP) swab
• (1) Nasal (anterior nares) swab

Volume:
Swab

Transport Media:
• Universal Transport Media (UTM)
• eSwab
• Saline (sterile)
• Viral Transport Media (VTM), including M4RT, M5, or M6

Specimen Requirements – Lower Respiratory

Type:
• Aspirate, tracheal
• Bronchoalveolar Lavage (BAL)
• Sputum

Volume:
1 mL

Transport Container:
Sterile container

If aliquotting is necessary, sterile aliquot tubes must be used. Do not dilute with UTM or VTM.

Transport Temperature

Refrigerated; transport to the laboratories on cold packs or wet ice.

Stability, Upper Resp.

Ambient:
Unacceptable

Refrigerated (2-8ºC):
3 days

Frozen:
Up to 30 days

Stability, Lower Resp.

Ambient:
Unacceptable

Refrigerated (2-8ºC):
7 days

Frozen:
Up to 30 days

Rejection Criteria

Swabs used for Group A Strep testing are not acceptable.

Ready to Place an Order?

Download and complete a Respiratory Virus Testing Requisition (required).

Need to Set Up an Account?

Request support from a regional Sales Manager or contact Laboratory Customer Service for general inquiries.

Specimen Collection Instructions

You will need:

Personal protective equipment (PPE)

(1) tube of transport medium

– Universal Transport Media (UTM)
– Viral Transport Media (VTM)
– Saline solution

(1) swab

Patient identification labels

Before you begin:

• Confirm the patient’s name and date of birth.

• Wash your hands, then put on personal protective equipment, including gloves.

If you are having difficulties obtaining appropriate COVID-19 specimen collection and transport supplies, please contact your CCL Account Manager.

Nasopharyngeal (NP) Swabs

Step 1:
Carefully remove the swab from the packaging without touching the tip.

Step 2a for nasopharyngeal (NP) swabs:

– Gently insert the NP swab along the nasal septum just above the floor of the passage to the nasopharynx until resistance is met.

– Rotate the swab gently against the nasopharyngeal mucosa for 10 – 15 seconds, then remove.

Step 3:
Remove the cap from the tube, then insert the swab all the way to the bottom of the vial.

Step 4:
While holding the tube away from your face, bend the swab in the vial at a 180-degree angle to break at the marked breakpoint.

Step 5:
Close the tube tightly. If possible, wrap the cap with Parafilm.

Any leaking specimens will be rejected.

Step 6:
Label specimen with the printed label or write the patient’s first & last name, date of birth, and the date, time, and site of collection (e.g., NP) on the tube.

Step 7:
Double-bag the specimen, place on wet ice, then refrigerate.

Step 8:
Complete a Respiratory Virus Test Requisition.

Step 9:
Place the completed requisition in the pocket of the specimen bag.

Do not place any paperwork in the part of the bag containing the specimen.

Step 10:
For the fastest turnaround time, deliver the specimen directly to the Main Campus LL Building Specimen Receiving Area:

Cleveland Clinic Laboratories
10300 Carnegie Avenue
Cleveland, OH 44106

Need a Respiratory Virus Test Requisition? 

Contact your CCL Sales Manager or Laboratory Customer Service.

Nasal (Anterior Nares) Swabs

Specimen Collection:

Step 1:Carefully remove the swab from the packaging without touching the tip.

Step 2:

Position the patient’s head slightly back, then insert the swab into their LEFT nostril (less than one inch) and gently push until a slight resistance is met.

Step 3:

Rotate the swab against the inside of the patient’s nostril four times for 10-15 seconds.

Step 4:
Remove the swab, then repeat Steps 2 & 3 in the RIGHT nostril with the same swab.

Remove the swab from the patient’s nose when finished.

Preparing for Transport:

Step 5:

While holding the swab, open the tube and set the cap down with the threads facing up.

Insert the swab into the tube until the breakpoint is level with the tube opening.

Step 6:

While holding the tube away from your face, bend the swab until it snaps at the break point.

You may need to gently rotate the swab shaft to complete the breakage.

Step 7:

After discarding the remaining swab shaft into an approved disposal container, screw the cap back onto the tube.

Apply the test label or write the patient’s information onto the tube.

Step 8:

Place the specimen into a biohazard bag, then insert any lab paperwork into the outside pouch.

Refrigerate the specimen during storage and transport to the lab.

If you have any questions, please contact your CCL Sales Manager or Laboratory Customer Service for assistance.

Increased Cyclospora Activity and Recommended Testing

Special Communication

Increased Cyclospora Activity and Recommended Testing

July 2026.

We would like to make providers aware of increased Cyclospora activity during the current transmission season. According to the CDC, 1,645 confirmed cases (5000 being investigated) domestically acquired cases have been reported across 34 states as of July 2026, and investigations are ongoing. No single source has been identified at this time. 

We have also observed an increase in Cyclospora-positive cases within our patient population, including both travel-associated but especially in locally acquired infections.

In response, Cleveland Clinic Laboratories is providing this dashboard with daily updates on CRYSPO testing volume, positive detections, and positivity rates to support clinical and public health decision-making.

Recommended testing:

For patients with suspected Cyclospora infection, particularly those with persistent or relapsing diarrhea, please order: CRYSPO – Cyclospora Modified Acid-Fast (MAF) Stain.
Please note that Cyclospora is not detected by routine Ova and Parasite (O&P) examination and requires alternative staining and test.

The Expanded Gastrointestinal Panel (STGIPI) includes a Cyclospora nucleic acid amplification target, but this is an expensive test and might not be reimbursed by insurance. CRYSPO is the preferred test for routine evaluation of suspected Cyclospora infection, as modified acid-fast staining allows direct visualization of Cyclospora oocysts within the stool specimen, providing evidence of active infection and supporting diagnosis in patients with ongoing or persistent symptoms.

Additional information:
Cyclosporiasis is a nationally notifiable disease. Cases identified through laboratory testing are automatically reported to the appropriate public health authorities in accordance with reporting requirements. Additional information is available through the CDC Cyclospora surveillance page:

CDC Cyclosporiasis Surveillance

March 2026: New Chemistry Standard Transport Tube

Special Communication

New Chemistry Standard Transport Tube

Effective March 9, 2026.

New Chemistry Standard Transport Tube Implemented for All Cleveland Clinic Locations

A new standard transport tube will be implemented for all Cleveland Clinic locations and clients on March 9, 2026. This new tube will replace the existing transport tube (Sarstedt product number 62.612) for most specimens that need to be aliquoted. The existing transport tube will no longer be accepted after March 31. Please refer to the test directory or procedure catalog for test-specific requirements.

March 2025: Test Changes to Oxidized Low-Density-Lipoprotein & Lipoprotein-associated Phospholipase A2 Activity

Special Communication

Test Changes – Oxidized Low-Density-Lipoprotein (OXLDL) & Lipoprotein-associated Phospholipase A2 Activity (PLAA2)

Effective March 18, 2025.

Starting March 18, 2025, Oxidized Low-Density-Lipoprotein (OXLDL) & Lipoprotein-associated Phospholipase A2 Activity (PLAA2) will be sent to a different performing reference laboratory (LabCorp).

Refer to the table below for an outline of testing changes.

Please contact Client Services with any questions or for assistance.

Test Change Overview

Lipoprotein-associated Phospholipase A2 Activity (Lp-PLA2 Activity) (PLAA2)

New Test

Old Test

Performing Laboratory

LabCorp

Cleveland HeartLab

Methodology

Spectrophotometric/Enzymatic assay

Enzymatic assay

Specimen Collection

Serum, 0.5 mL

Gold Serum Separation Tube (SST)

Serum

Minimum Volume

0.2 mL

0.5 mL

Transport Temperature

Refrigerated

Refrigerated

Reference Interval

<225 nmol/min/mL

≤123 nmol/min/mL

Please note the change in units and reference interval.

Turnaround Time

3-5 days

4-5 days

Oxidized Low-Density-Lipoprotein (OXLDL)

New Test

Old Test

Performing Laboratory

LabCorp

Cleveland HeartLab

Methodology

Enzyme-Linked Immunosorbent Assay (ELISA)

Enzyme-Linked Immunosorbent Assay (ELISA)

Specimen Collection

Plasma, 0.5 mL

Lavender K2EDTA Tube

Plasma

Lavender K2EDTA Tube

Minimum Volume

0.2 mL

0.2 mL

Transport Temperature

Critical frozen

Refrigerated

Reference Interval

10-170 ng/mL

<60 U/L

Please note the change in units and reference interval.

Turnaround Time

4-6 days

2-6 days

October 2024: Stool Testing Universal Laboratory (STUL) Kit for Microbiology

Special Communication

Stool Testing Universal Laboratory (STUL) Kit for Microbiology

Effective October 1, 2024.

The Stool Testing Universal Laboratory (STUL) Kit for Microbiology contains the collection and transport items necessary for most stool testing.

Place all (3) vials into the white STUL Kit bag or a large biohazard bag with Beaker labels attached externally.

All vials remain at Main Campus for add-on testing, stability permitting. Refer to the Microbiology Collection & Transport Guide: Stool Collection Devices for specific test and item information.

September 2024: Test Update – Vasoactive Intestinal Polypeptide (VIP), Plasma

Special Communication

Test Update – Vasoactive Intestinal Polypeptide, Plasma (VIP)

Effective October 8, 2024.

Beginning October 8, 2024, Vasoactive Intestinal Polypeptide, Plasma (VIP) will return to the previous reference lab following the resolution of the reagent shortage.

Refer to the table below for an outline of testing changes.

Please contact Client Services with any questions or for assistance.

Test Change Overview

Vasoactive Intestinal Polypeptide, Plasma (VIP)

For specimens collected between 9/17/24 and 10/8/24, the VIP order will be canceled and replaced by a MISC1 test due to the test at Mayo being discontinued as of 9/17/24 with no advance notice.  The specimen will be sent to ARUP and results will be uploaded as a PDF when they are received.

New Test

Old Test

Performing Laboratory

ARUP

Mayo Clinic Laboratories

Methodology

Enzyme-linked immunosorbent assay (ELISA)

Enzyme-linked immunosorbent assay (ELISA)

Specimen Collection

Plasma, 2 mL

Lavender K2EDTA tube

Plasma, 1 mL

Lavender K2EDTA tube

Minimum Volume

0.5 mL

0.5 mL

Transport Temperature

Critical frozen

Critical frozen

Reference Interval

0-89.1 pg/mL

0-36 pg/mL

Turnaround Time

4-8 days

6-10 days

Vendor Test Information

TEST ID : FVIP2

Sept 2024: Immediate Test Change – Testosterone, Free and Total

Immediate Test Change

Test Update – Testosterone, Free and Total (TFTEST)

Effective September 12, 2024.

Beginning September 12, 2024, Testosterone, Free and Total (TFTEST) will be sent to a different reference laboratory due to an emergency inactivation at the current reference laboratory because of reagent problems.

This follows an extended test delay since April of this year.

Please contact Client Services with any questions or for assistance.

For specimens ordered and collected before September 12, 2024, but not received by Mayo before September 12, 2024, Mayo will send them to LabCorp for testing. When available, those results will be uploaded as scanned documents to the lab order.

Test Change Overview

Testosterone, Free and Total (TFTEST)

As part of this change, the test’s name has been modified to clarify its contents and how it is performed. Test name changes for the other testosterone assays are planned for later this fall.

New Test

Old Test

Test Name

Testosterone, free and total, by equilibrium ultrafiltration mass spectrometry

Testosterone, Free and Total

Performing Laboratory

LabCorp

Mayo Clinic Laboratories

Methodology

Equilibrium ultrafiltration; Liquid chromatography/tandem mass spectrometry

Equilibrium dialysis; Liquid chromatography/tandem mass spectrometry

Specimen Collection

Serum, 2.2 mL

Red (No Additive) Tube

Serum, 2.5 mL

Red (No Additive) Tube

Minimum Volume

1.8 mL

1 mL

Transport Temperature

Ambient

Refrigerated

Turnaround Time

5-7 days

4-8 days (delay as of April 19, 2024)

Vendor Test Information

June 2024: Test Update – Vasoactive Intestinal Polypeptide (VIP), Plasma

Immediate Test Change

Test Update – Vasoactive Intestinal Polypeptide, Plasma (VIP)

Effective June 27, 2024.

Beginning June 27, 2024, Vasoactive Intestinal Polypeptide, Plasma (VIP) will be sent to a different reference laboratory due to issues with the current reagent manufacturer.

Refer to the table below for an outline of testing changes.

Please contact Client Services with any questions or for assistance.

Test Change Overview

Vasoactive Intestinal Polypeptide, Plasma (VIP)

Additional patient preparation information for the new test:
Patients must fast for 10-12 hours and avoid antacid medications or medications that affect intestinal motility for at least 48 hours before collection.

New Test

Old Test

Performing Laboratory

Mayo Clinic Laboratories

ARUP

Methodology

Enzyme-linked immunosorbent assay (ELISA)

Radioimmunoassay (RIA) 

Specimen Collection

Plasma, 1 mL

Lavender K2EDTA tube

Plasma, 1 mL

PPACK tube

Minimum Volume

0.5 mL

0.5 mL

Transport Temperature

Critical frozen

Frozen

Reference Interval

0-36 pg/mL

0-60 pg/mL 

Turnaround Time

6-10 days

4-8 days 

Vendor Test Information

November 2023: Product Discontinuation – BD CultureSwab™

Immediate Test Change

Product Discontinuation: BD CultureSwab™ Liquid Amies Double Swab

Effective November 14, 2023.

Replacements: eSwab™ or Cepheid Collection Device

The eSwab™ (Copan Diagnostics) collection device—utilized by Cleveland Clinic for 8+ years—will now be the primary swab for bacteriology.

No change to the swabbing collection process is needed when using an eSwab™.

Although typically tissue or fluid is a superior quality sample for bacteriology, collecting a swab is often more feasible. The eSwab™ uses a patented flocked swab, which enables the elution of the primary sample into 1 mL of liquid contained within the collection tube. The bacteriology laboratory then uses this liquid for testing.

Swab discontinued by the manufacturer.

Choose the appropriate collection device: 

eSwab™

Use for:
Group A Strep PCR GASPCR

Fungal Screen for Candida FUNGSC

Bacteriology cultures:
• Abscess & Wound Culture WCUL
• Anaerobe Culture ANACUL
• Cystic Fibrosis Respiratory Culture CFRCUL
• Ear Culture & Stain EARCSM
• Eye Culture & Stain EYECSM
• MRSA culture screen MRSASC
• MRSA/S. aureus culture screen SANSAL
• Throat Culture THRCUL
• VRE Culture VRESC

Cepheid Collection Device

Use for:
Routine Prenatal Group B PCR GBPCR

S. aureus PCR SAPCR

November 2023: Test Update – Chromogranin A, New Assay

Immediate Test Change

Test Update – Chromogranin A (CHROMA), New Assay

Effective November 9, 2023.

Chromogranin A (CHROMAwill be updated to a new assay effective November 9, 2023.

The results of the current and new tests are not interchangeable. Due to a reagent shortage, the laboratory will not be able to undergo a rebaseline/parallel testing process.

Please contact Client Services for laboratory assistance with interpreting results in patients undergoing serial monitoring.

Test Change Overview

Chromogranin A (CHROMA)

Update?

Details

Methodology

Yes

New Assay:
Immunoassay, BRAHMS CGA II Kryptor Kit

Discontinued:
Cisbio CGA II, ELISA

The results in the new assay are, on average, 20% lower than the previous assay. The bias is more pronounced at concentrations below 200 ng/mL, where the observed bias is 30%.

Test Code

No

Specimen

No

Type
Serum

Container
Gold Serum Separator Tube, or
Red Plain (No Additive) Tube

Stability

Yes

Ambient:
48 hours

Refrigerated:
48 hours

Frozen:
3 months

Transport samples frozen.

Days Performed

Yes

Days Performed
Tuesday, Friday

Reported
1-4 days

Reporting

Yes

Reference Interval
<187 ng/mL

The results of the new and old assays will not trend together in the laboratory information system (e.g., Beaker/EPIC).